Children as young as six to be tested for Oxford/AstraZeneca vaccine efficacy

5338.jpg?width=1200&height=630&quality=8

Trial will use 300 volunteers to assess whether jab produces strong immune response in children aged six to 17

The efficacy of the Oxford/AstraZeneca vaccine in children is due to be tested in a new clinical trial beginning this month.

Researchers will use 300 volunteers to assess whether the jab – known as the the ChAdOx1 nCoV-19 vaccine – produces a strong immune response in children aged between six and 17.

Continue reading…